$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What are the contraindications to the use of Quizartinib? Who is not suitable to use this medicine?
2026-02-01 22:25:32
Check Details
What is tucatinib? What kind of targeted therapy drug does it belong to?
2026-02-01 22:25:32
Check Details
How long does it take for Apelvis to take effect? What are the factors that affect the efficacy of
2026-02-01 22:25:32
Check Details
How effective is selumetinib in treating neurofibromatosis? Can it alleviate the condition in the long term?
2026-02-01 22:25:32
Check Details
How effective is cabozantinib in the treatment of brain metastases? Whether the disease can be effectively controlled
2026-02-01 22:25:32
Check Details
How long should I take bedaquiline? What medication schedule needs to be followed during treatment?
2026-02-01 22:25:32
Check Details
What is the dosage of dasatinib? How to adjust the dose according to the patient's condition?
2026-02-01 22:25:32
Check Details
Can Anamorelin be used long term? Safety and potential risks of long-term use
2026-02-01 22:25:32
Check Details
Can't I stop taking baricitinib once I start taking it? Long-term use requirements and discontinuation precautions
2026-02-01 22:25:32
Check Details
Is ruxolitinib cream effective in treating eczema? How it compares to other eczema treatments
2026-02-01 22:25:32
Check Details
Will upadatinib develop wildly after discontinuation? Is there a risk of recurrence or worsening of symptoms after discontinuing medication?
2026-02-01 22:25:32
Check Details
Pitobrutinib/pitobrutinib receives positive CHMP review for R/R CLL following use of covalent BTK inhibitor
2026-02-01 22:25:32
Check Details
1
2
...
1434
1435
1436
1437
1438
1439
1440
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
2
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
3
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
4
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
5
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
6
User Agreement
7
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
8
What is the most important information I should know about WELIREG?
9
How to take and store WELIREG
10
How to take TRUSELTIQ correctly
11
How to deal with LONSURF side effects (1)
12
How to deal with LONSURF side effects (2)